Population stratification in type 2 diabetes mellitus: A systematic review
Sam Hodgson1, Sukhmani Cheema2, Zareena Rani2
1NIHR Academic Clinical Fellow, Primary Care Research Centre, University of Southampton, Southampton, UK.
Diabetic Medicine : a Journal of the British Diabetic Association
|September 14, 2021
Summary
Stratification in type 2 diabetes research is mostly expert-driven, using variables like HbA1c. Data-driven methods are rare but offer potential for new insights into disease management and outcomes.
Area of Science:
- Endocrinology and Metabolism
- Public Health and Epidemiology
- Biostatistics
Background:
- Type 2 diabetes management increasingly uses population stratification to personalize care and improve patient outcomes.
- Systematic reviews are crucial for understanding current stratification methodologies in type 2 diabetes research.
Purpose of the Study:
- To systematically review and collate literature on population stratification methods in adults with type 2 diabetes.
- To describe and compare stratification methodologies, population characteristics, variables, and outcomes used in existing studies.
Main Methods:
- Searched MEDLINE, EMBASE, CINAHL, and Cochrane databases up to July 2020.
- Included studies on adults with type 2 diabetes using population stratification.
- Followed PRISMA guidance and registered the protocol on PROSPERO (ID: CRD42020206604).
Main Results:
- Analyzed 348 studies involving over 10.7 million participants (mean age 61.0 years).
- 6.7% of studies employed data-driven stratification; the remainder used expert-driven approaches.
- HbA1c was the most common stratification variable; few studies used non-traditional variables like health behaviors.
Conclusions:
- Most type 2 diabetes stratification studies are expert-driven, focusing on predicting glycemic control, mortality, and cardiovascular outcomes.
- Data-driven approaches are underutilized but offer potential for hypothesis generation beyond current knowledge.
- Research gaps exist, particularly in stratification related to type 2 diabetes remission.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
3.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.4K
Diabetes Mellitus: Overview and Type I Subtype
3.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.8K
Carbohydrate Metabolism
12.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.6K
Pathophysiology of Diabetes
2.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications
1.3K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Diabetes: Management and Pharmacotherapy
575
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
575


